Long‐term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype
- 10 May 1993
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 16 (6), 1024-1033
- https://doi.org/10.1007/bf00711520
Abstract
Two mucopolysaccharidosis type I (MPS‐I) patients, subjected to bone marrow transplantation (BMT) more than 10 years ago, have recently had their α‐L‐iduronidase genotypes defined. Both patients, hom...Keywords
This publication has 9 references indexed in Scilit:
- Structure and sequence of the human α-l-iduronidase geneGenomics, 1992
- Amelioration of clinical disease following bone marrow transplantation in fucosidase‐deficient dogsAmerican Journal of Medical Genetics, 1992
- α-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotypeHuman Mutation, 1992
- A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotypeHuman Mutation, 1992
- Human alpha-L-iduronidase: cDNA isolation and expression.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Bone Marrow Transplantation in the Treatment of Lysosomal Storage DiseasesPublished by Springer Science and Business Media LLC ,1990
- Diagnostic Enzymology of a-L-Iduronidase with Special Reference to a Sulphated Disaccharide Derived from HeparinClinical Science, 1982
- High-resolution electrophoresis of urinary glycosaminoglycans: An improved screening test for the mucopolysaccharidosesAnalytical Biochemistry, 1982
- REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATIONThe Lancet, 1981